Incidental Prostate Cancer: A Real Need for Expansion in Guidelines?

In this issue of European Urology Oncology, Capitano and colleagues [1] recommend that incidental prostate cancer (PCa), classified as T1a or T1b PCa, should be clearly discussed in international guidelines because it represents a different clinical situation compared to T1c PCa. Indeed, T1a/b PCa is mentioned only once in the recently updated European Association of Urology guidelines [2]. Is it really a major issue not to expand on this?